highly significantP <0.001
Evaluation of the CA-125 levels revealed that 25 (71.4%) benign cases had a CA-125 <35 and 10 (28.6%) benign cases had CA-125 ≥35, whereas in the malignant group, 18 (78.3%) cases had an elevated CA-125 ≥35, representing a highly significant difference ( P <0.001) ( Table 3 ).